Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Multicenter Analysis of Dosing Protocols for Sotalol Initiation.

Biswas M, Levy A, Weber R, Tarakji K, Chung M, Noseworthy PA, Newton-Cheh C, Rosenberg MA.

J Cardiovasc Pharmacol Ther. 2019 Nov 10:1074248419887710. doi: 10.1177/1074248419887710. [Epub ahead of print]

PMID:
31707834
2.

A Latent Class Approach to Modeling Trajectories of Health Care Cost in Pediatric Cystic Fibrosis.

Levy JF, Rosenberg MA.

Med Decis Making. 2019 Jul;39(5):593-604. doi: 10.1177/0272989X19859875. Epub 2019 Aug 13.

PMID:
31409187
3.

Frailty, Implantable Cardioverter Defibrillators, and Mortality: a Systematic Review.

Chen MY, Orkaby AR, Rosenberg MA, Driver JA.

J Gen Intern Med. 2019 Oct;34(10):2224-2231. doi: 10.1007/s11606-019-05100-9. Epub 2019 Jul 1.

PMID:
31264082
4.

Device-measured physical activity data for classification of patients with ventricular arrhythmia events: A pilot investigation.

Marzec L, Raghavan S, Banaei-Kashani F, Creasy S, Melanson EL, Lange L, Ghosh D, Rosenberg MA.

PLoS One. 2018 Oct 29;13(10):e0206153. doi: 10.1371/journal.pone.0206153. eCollection 2018.

5.

Multi-ethnic genome-wide association study for atrial fibrillation.

Roselli C, Chaffin MD, Weng LC, Aeschbacher S, Ahlberg G, Albert CM, Almgren P, Alonso A, Anderson CD, Aragam KG, Arking DE, Barnard J, Bartz TM, Benjamin EJ, Bihlmeyer NA, Bis JC, Bloom HL, Boerwinkle E, Bottinger EB, Brody JA, Calkins H, Campbell A, Cappola TP, Carlquist J, Chasman DI, Chen LY, Chen YI, Choi EK, Choi SH, Christophersen IE, Chung MK, Cole JW, Conen D, Cook J, Crijns HJ, Cutler MJ, Damrauer SM, Daniels BR, Darbar D, Delgado G, Denny JC, Dichgans M, Dörr M, Dudink EA, Dudley SC, Esa N, Esko T, Eskola M, Fatkin D, Felix SB, Ford I, Franco OH, Geelhoed B, Grewal RP, Gudnason V, Guo X, Gupta N, Gustafsson S, Gutmann R, Hamsten A, Harris TB, Hayward C, Heckbert SR, Hernesniemi J, Hocking LJ, Hofman A, Horimoto ARVR, Huang J, Huang PL, Huffman J, Ingelsson E, Ipek EG, Ito K, Jimenez-Conde J, Johnson R, Jukema JW, Kääb S, Kähönen M, Kamatani Y, Kane JP, Kastrati A, Kathiresan S, Katschnig-Winter P, Kavousi M, Kessler T, Kietselaer BL, Kirchhof P, Kleber ME, Knight S, Krieger JE, Kubo M, Launer LJ, Laurikka J, Lehtimäki T, Leineweber K, Lemaitre RN, Li M, Lim HE, Lin HJ, Lin H, Lind L, Lindgren CM, Lokki ML, London B, Loos RJF, Low SK, Lu Y, Lyytikäinen LP, Macfarlane PW, Magnusson PK, Mahajan A, Malik R, Mansur AJ, Marcus GM, Margolin L, Margulies KB, März W, McManus DD, Melander O, Mohanty S, Montgomery JA, Morley MP, Morris AP, Müller-Nurasyid M, Natale A, Nazarian S, Neumann B, Newton-Cheh C, Niemeijer MN, Nikus K, Nilsson P, Noordam R, Oellers H, Olesen MS, Orho-Melander M, Padmanabhan S, Pak HN, Paré G, Pedersen NL, Pera J, Pereira A, Porteous D, Psaty BM, Pulit SL, Pullinger CR, Rader DJ, Refsgaard L, Ribasés M, Ridker PM, Rienstra M, Risch L, Roden DM, Rosand J, Rosenberg MA, Rost N, Rotter JI, Saba S, Sandhu RK, Schnabel RB, Schramm K, Schunkert H, Schurman C, Scott SA, Seppälä I, Shaffer C, Shah S, Shalaby AA, Shim J, Shoemaker MB, Siland JE, Sinisalo J, Sinner MF, Slowik A, Smith AV, Smith BH, Smith JG, Smith JD, Smith NL, Soliman EZ, Sotoodehnia N, Stricker BH, Sun A, Sun H, Svendsen JH, Tanaka T, Tanriverdi K, Taylor KD, Teder-Laving M, Teumer A, Thériault S, Trompet S, Tucker NR, Tveit A, Uitterlinden AG, Van Der Harst P, Van Gelder IC, Van Wagoner DR, Verweij N, Vlachopoulou E, Völker U, Wang B, Weeke PE, Weijs B, Weiss R, Weiss S, Wells QS, Wiggins KL, Wong JA, Woo D, Worrall BB, Yang PS, Yao J, Yoneda ZT, Zeller T, Zeng L, Lubitz SA, Lunetta KL, Ellinor PT.

Nat Genet. 2018 Jun 11;50(9):1225-1233. doi: 10.1038/s41588-018-0133-9.

6.

Serum androgens and risk of atrial fibrillation in older men: The Cardiovascular Health Study.

Rosenberg MA, Shores MM, Matsumoto AM, Bůžková P, Lange LA, Kronmal RA, Heckbert SR, Mukamal KJ.

Clin Cardiol. 2018 Jun;41(6):830-836. doi: 10.1002/clc.22965. Epub 2018 Jun 8.

7.

Validation of Polygenic Scores for QT Interval in Clinical Populations.

Rosenberg MA, Lubitz SA, Lin H, Kosova G, Castro VM, Huang P, Ellinor PT, Perlis RH, Newton-Cheh C.

Circ Cardiovasc Genet. 2017 Oct;10(5). pii: e001724. doi: 10.1161/CIRCGENETICS.117.001724.

8.

Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis.

Roetker NS, Armasu SM, Pankow JS, Lutsey PL, Tang W, Rosenberg MA, Palmer TM, MacLehose RF, Heckbert SR, Cushman M, de Andrade M, Folsom AR.

J Thromb Haemost. 2017 Jul;15(7):1334-1343. doi: 10.1111/jth.13719. Epub 2017 Jun 6.

9.

Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.

Strauss DG, Vicente J, Johannesen L, Blinova K, Mason JW, Weeke P, Behr ER, Roden DM, Woosley R, Kosova G, Rosenberg MA, Newton-Cheh C.

Circulation. 2017 Apr 4;135(14):1300-1310. doi: 10.1161/CIRCULATIONAHA.116.023980. Epub 2017 Feb 17.

10.

Innovative assessment of inpatient and pulmonary drug costs for children with cystic fibrosis.

Levy JF, Rosenberg MA, Farrell PM.

Pediatr Pulmonol. 2016 Dec;51(12):1295-1303. doi: 10.1002/ppul.23554. Epub 2016 Oct 14.

PMID:
27740724
11.

Measures of Body Size and Composition and Risk of Incident Atrial Fibrillation in Older People: The Cardiovascular Health Study.

Karas MG, Yee LM, Biggs ML, Djoussé L, Mukamal KJ, Ix JH, Zieman SJ, Siscovick DS, Gottdiener JS, Rosenberg MA, Kronmal RA, Heckbert SR, Kizer JR.

Am J Epidemiol. 2016 Jun 1;183(11):998-1007. doi: 10.1093/aje/kwv278. Epub 2016 May 5.

12.

Left ventricular sphericity independently predicts appropriate implantable cardioverter-defibrillator therapy.

Levine YC, Matos J, Rosenberg MA, Manning WJ, Josephson ME, Buxton AE.

Heart Rhythm. 2016 Feb;13(2):490-7. doi: 10.1016/j.hrthm.2015.09.022. Epub 2015 Sep 25.

PMID:
26409099
13.

Prevalence and outcomes of patients receiving implantable cardioverter-defibrillators for primary prevention not based on guidelines.

Levine YC, Tuttle MK, Rosenberg MA, Goldberg R, Matos J, Samuel M, Kramer DB, Buxton AE.

Am J Cardiol. 2015 Jun 1;115(11):1539-44. doi: 10.1016/j.amjcard.2015.02.056. Epub 2015 Mar 12.

14.

A Novel Computerized Portable Pupillometer Detects and Quantifies Relative Afferent Pupillary Defects.

Cohen LM, Rosenberg MA, Tanna AP, Volpe NJ.

Curr Eye Res. 2015;40(11):1120-7. doi: 10.3109/02713683.2014.980007. Epub 2015 Feb 6.

PMID:
25658805
15.

US-Based Drug Cost Parameter Estimation for Economic Evaluations.

Levy JF, Meek PD, Rosenberg MA.

Med Decis Making. 2015 Jul;35(5):622-32. doi: 10.1177/0272989X14563987. Epub 2014 Dec 22.

16.

Genetic variants related to height and risk of atrial fibrillation: the cardiovascular health study.

Rosenberg MA, Kaplan RC, Siscovick DS, Psaty BM, Heckbert SR, Newton-Cheh C, Mukamal KJ.

Am J Epidemiol. 2014 Jul 15;180(2):215-22. doi: 10.1093/aje/kwu126. Epub 2014 Jun 18.

17.

B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias.

Levine YC, Rosenberg MA, Mittleman M, Samuel M, Methachittiphan N, Link M, Josephson ME, Buxton AE.

Heart Rhythm. 2014 Jul;11(7):1109-16. doi: 10.1016/j.hrthm.2014.04.024. Epub 2014 May 13.

PMID:
24837348
18.

SIRT2 induces the checkpoint kinase BubR1 to increase lifespan.

North BJ, Rosenberg MA, Jeganathan KB, Hafner AV, Michan S, Dai J, Baker DJ, Cen Y, Wu LE, Sauve AA, van Deursen JM, Rosenzweig A, Sinclair DA.

EMBO J. 2014 Jul 1;33(13):1438-53. doi: 10.15252/embj.201386907. Epub 2014 May 12.

19.

Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS).

Rosenberg MA, Maziarz M, Tan AY, Glazer NL, Zieman SJ, Kizer JR, Ix JH, Djousse L, Siscovick DS, Heckbert SR, Mukamal KJ.

Am Heart J. 2014 May;167(5):723-8.e2. doi: 10.1016/j.ahj.2014.01.010. Epub 2014 Feb 26.

20.

To the editor--Spontaneous conversion of a long RP to short RP tachycardia: what is the mechanism?

Rosenberg MA, Gandhavadi M, Tan AY.

Heart Rhythm. 2014 Jun;11(6):E5. doi: 10.1016/j.hrthm.2014.04.005. Epub 2014 Apr 12. No abstract available.

PMID:
24726976
21.

Height and risk of sudden cardiac death: the Atherosclerosis Risk in Communities and Cardiovascular Health studies.

Rosenberg MA, Lopez FL, Bůžková P, Adabag S, Chen LY, Sotoodehnia N, Kronmal RA, Siscovick DS, Alonso A, Buxton A, Folsom AR, Mukamal KJ.

Ann Epidemiol. 2014 Mar;24(3):174-179.e2. doi: 10.1016/j.annepidem.2013.11.008. Epub 2013 Nov 26.

22.

Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011.

Stout NK, Nekhlyudov L, Li L, Malin ES, Ross-Degnan D, Buist DS, Rosenberg MA, Alfisher M, Fletcher SW.

JAMA Intern Med. 2014 Jan;174(1):114-21. doi: 10.1001/jamainternmed.2013.11958.

23.
24.

Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis.

Batina NG, Trentham-Dietz A, Gangnon RE, Sprague BL, Rosenberg MA, Stout NK, Fryback DG, Alagoz O.

Breast Cancer Res Treat. 2013 Apr;138(2):519-28. doi: 10.1007/s10549-013-2435-z. Epub 2013 Feb 16.

25.

Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study.

Rosenberg MA, Samuel M, Thosani A, Zimetbaum PJ.

Pacing Clin Electrophysiol. 2013 Mar;36(3):328-33. doi: 10.1111/pace.12053. Epub 2012 Dec 13.

26.

Derivation of background mortality by smoking and obesity in cancer simulation models.

Wang YC, Graubard BI, Rosenberg MA, Kuntz KM, Zauber AG, Kahle L, Schechter CB, Feuer EJ.

Med Decis Making. 2013 Feb;33(2):176-97. doi: 10.1177/0272989X12458725. Epub 2012 Nov 6.

27.

Diastolic dysfunction and risk of atrial fibrillation: a mechanistic appraisal.

Rosenberg MA, Manning WJ.

Circulation. 2012 Nov 6;126(19):2353-62. doi: 10.1161/CIRCULATIONAHA.112.113233. Review. No abstract available.

PMID:
23129702
28.

The impact of height on the risk of atrial fibrillation: the Cardiovascular Health Study.

Rosenberg MA, Patton KK, Sotoodehnia N, Karas MG, Kizer JR, Zimetbaum PJ, Chang JD, Siscovick D, Gottdiener JS, Kronmal RA, Heckbert SR, Mukamal KJ.

Eur Heart J. 2012 Nov;33(21):2709-17. doi: 10.1093/eurheartj/ehs301. Epub 2012 Sep 12.

29.

Chapter 3: Cohort life tables by smoking status, removing lung cancer as a cause of death.

Rosenberg MA, Feuer EJ, Yu B, Sun J, Henley SJ, Shanks TG, Anderson CM, McMahon PM, Thun MJ, Burns DM.

Risk Anal. 2012 Jul;32 Suppl 1:S25-38. doi: 10.1111/j.1539-6924.2011.01662.x.

30.

The Estimated Risk of Atrial Fibrillation Related to Alcohol Consumption.

Rosenberg MA, Mukamal KJ.

J Atr Fibrillation. 2012 Jun 15;5(1):424. doi: 10.4022/jafib.424. eCollection 2012 Jun-Jul. Review.

31.

A Novel Transgenic Mouse Model of Cardiac Hypertrophy and Atrial Fibrillation.

Rosenberg MA, Das S, Quintero Pinzon P, Knight AC, Sosnovik DE, Ellinor PT, Rosenzweig A.

J Atr Fibrillation. 2012 Feb 2;4(5):415. doi: 10.4022/jafib.415. eCollection 2012 Feb-Mar. Review.

32.

Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study.

Rosenberg MA, Gottdiener JS, Heckbert SR, Mukamal KJ.

Eur Heart J. 2012 Apr;33(7):904-12. doi: 10.1093/eurheartj/ehr378. Epub 2011 Oct 11.

33.

The nuclear receptor corepressor (NCoR) controls thyroid hormone sensitivity and the set point of the hypothalamic-pituitary-thyroid axis.

Astapova I, Vella KR, Ramadoss P, Holtz KA, Rodwin BA, Liao XH, Weiss RE, Rosenberg MA, Rosenzweig A, Hollenberg AN.

Mol Endocrinol. 2011 Feb;25(2):212-24. doi: 10.1210/me.2010-0462. Epub 2011 Jan 14.

34.

mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy.

Song X, Kusakari Y, Xiao CY, Kinsella SD, Rosenberg MA, Scherrer-Crosbie M, Hara K, Rosenzweig A, Matsui T.

Am J Physiol Cell Physiol. 2010 Dec;299(6):C1256-66. doi: 10.1152/ajpcell.00338.2010. Epub 2010 Sep 22.

35.

Optic disk excavation in nonarteritic anterior ischemic optic neuropathy.

Punjabi OS, Tanna AP, Rosenberg MA.

J Glaucoma. 2011 Feb;20(2):71-3. doi: 10.1097/IJG.0b013e3181dddf5c.

PMID:
20436358
36.

Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt.

Morissette MR, Cook SA, Buranasombati C, Rosenberg MA, Rosenzweig A.

Am J Physiol Cell Physiol. 2009 Nov;297(5):C1124-32. doi: 10.1152/ajpcell.00043.2009. Epub 2009 Sep 16.

37.

Radiology faculty compliance with recommended health guidelines: comparison with residents.

Collins J, Hinshaw JL, Simcock E, Rosenberg MA.

Acad Radiol. 2009 Nov;16(11):1433-42. doi: 10.1016/j.acra.2009.06.011. Epub 2009 Aug 15.

PMID:
19683946
38.

Effects of myostatin deletion in aging mice.

Morissette MR, Stricker JC, Rosenberg MA, Buranasombati C, Levitan EB, Mittleman MA, Rosenzweig A.

Aging Cell. 2009 Sep;8(5):573-83. doi: 10.1111/j.1474-9726.2009.00508.x. Epub 2009 Aug 6.

39.

Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.

Noseworthy PA, Rosenberg MA, Fifer MA, Palacios IF, Lowry PA, Ruskin JN, Sanborn DM, Picard MH, Vlahakes GJ, Mela T, Das S.

Am J Cardiol. 2009 Jul 1;104(1):128-32. doi: 10.1016/j.amjcard.2009.02.056. Epub 2009 May 4.

PMID:
19576333
40.

Re: Lincoln in Connecticut.

Rosenberg MA.

Conn Med. 2009 Apr;73(4):245. No abstract available.

PMID:
19413092
41.

Annals of Civil War medicine: the court martial of Surgeon General William A. Hammond, MD.

Rosenberg MA.

Conn Med. 2009 Feb;73(2):121-2. No abstract available.

PMID:
19263748
42.

Medical tales from the "good war".

Rosenberg MA.

Conn Med. 2008 Sep;72(8):497-8. No abstract available.

PMID:
18798387
43.

A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.

Marbury TC, Schwartz S, Rosenberg MA, Jariwala N, Becker RH, Johnston PS.

Exp Clin Endocrinol Diabetes. 2008 May;116(5):282-8. doi: 10.1055/s-2007-1022521.

PMID:
18484560
44.

Recollections: going home--1945.

Rosenberg MA.

Conn Med. 2008 Feb;72(2):117-8. No abstract available.

PMID:
18306840
45.

Use and employer costs of a pharmacotherapy smoking-cessation treatment benefit.

Burns ME, Rosenberg MA, Fiore MC.

Am J Prev Med. 2007 Feb;32(2):139-42. Epub 2006 Dec 29.

PMID:
17196785
46.

Recollection: Christmas Eve in Cherbourg--1944.

Rosenberg MA.

Conn Med. 2006 Nov-Dec;70(10):637-8. No abstract available.

PMID:
17190393
47.

The Wisconsin Breast Cancer Epidemiology Simulation Model.

Fryback DG, Stout NK, Rosenberg MA, Trentham-Dietz A, Kuruchittham V, Remington PL.

J Natl Cancer Inst Monogr. 2006;(36):37-47.

PMID:
17032893
48.

Competing risks to breast cancer mortality.

Rosenberg MA.

J Natl Cancer Inst Monogr. 2006;(36):15-9.

PMID:
17032889
49.

Retrospective cost-effectiveness analysis of screening mammography.

Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG.

J Natl Cancer Inst. 2006 Jun 7;98(11):774-82.

PMID:
16757702
50.

Effect of a nutritional supplement on posaconazole pharmacokinetics following oral administration to healthy volunteers.

Sansone-Parsons A, Krishna G, Calzetta A, Wexler D, Kantesaria B, Rosenberg MA, Saltzman MA.

Antimicrob Agents Chemother. 2006 May;50(5):1881-3.

Supplemental Content

Loading ...
Support Center